Evon Poon

6PUBLICATIONS

97CO-AUTHORS

Predictive and prognostic markersHaematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 24, 2026

Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

|Sep 17, 2025

RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity.

Shivendra Singh, Jie Fang, Hongjian Jin

|May 03, 2024

A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.

Ingrid M Saldana-Guerrero, Luis F Montano-Gutierrez, Katy Boswell

|Jan 05, 2023

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Elizabeth R Tucker, Irene Jiménez, Lindi Chen

|Mar 17, 2022

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.

Anke Nijhuis, Arti Sikka, Orli Yogev

|Sep 15, 2021

The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme.

Zuzanna Urban-Wójciuk, Amy Graham, Karen Barker

Pageof 1

Frequent Collaborators

Louis Chesler

Yann Jamin

Karen T Barker

Barbara Martins Da Costa

Qiong Gao

Amy Graham

Patrick M Woster

Paul Workman

Gabriel N Valbuena

Yuewei Xu

Frequent Collaborators

Louis Chesler

Yann Jamin

Karen T Barker

Barbara Martins Da Costa